"The initial phase of large-scale production of the UQ COVID-19 vaccine is planned to take place at CSL’s biotech manufacturing facilities in Melbourne, Australia. While there are a number of critical milestones to be met before the vaccine can be considered successful, CSL anticipates that the production technology can be scaled to produce up to one hundred million doses towards the end of 2021. CSL would also subcontract other global manufacturers to increase the number of doses that can be produced and broaden the geographical distribution of vaccine production."
https://www.csl.com/news/2020/20200605-uq-cepi-and-csl-partner-for-covid-19-vaccine-candidate
"The initial phase of large-scale production of the UQ COVID-19...
-
- There are more pages in this discussion • 103 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$293.00 |
Change
2.260(0.78%) |
Mkt cap ! $141.5B | |||
| Open | High | Low | Value | Volume |
| $294.00 | $294.75 | $290.82 | $491.6M | 1.702M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8192 | $292.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $293.06 | 12368 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| CSL (ASX) Chart |